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There are expectations that stem cell therapy (SCT) will treat many currently untreat-
able diseases. The Internet is widely used by patients seeking information about new 
treatments, and hence, analyzing websites is a representative sample of the information 
available to the public. Our aim was to understand what information the public would 
find when searching for information on SCT on Google, as this would inform us on how 
lay people form their knowledge about SCT. We analyzed the content and information 
quality of the first 200 websites returned by a Google.com search on SCT. Most websites 
returned were from treatment centers (TCs, 44%) followed by news and medical profes-
sional websites. The specialty most mentioned in non-TC websites was “neurological” 
(67%), followed by “cardiovascular” (42%), while the most frequent indication for which 
SCT is offered by TCs was musculoskeletal (89%) followed by neurological (47%). 45% 
of the centers specialized in treating 1 specialty, 10% offer 2, and 45% offered between 
3 and 18 different specialties. Of the 78 TCs, 65% were in the USA, 23% in Asia, and 
8% in Latin America. None of the centers offered SCT based on embryonic cells. Health 
information quality (JAMA score, measuring trustworthiness) was lowest for TCs and 
commercial websites and highest for scientific journals and health portals. This study 
shows a disconnection between information about SCT and what is actually offered by 
TCs. The study also shows that TCs, potentially acting in a regulatory gray area, have a 
high visibility on the Internet.
Keywords: google, internet, health information, information quality, stem cell therapy, stem cells
inTrODUcTiOn
Stem cell therapy (SCT) offers much potential, and raises significant expectations. Scientific and lay 
discussion have linked SCT to an extensive spectrum of conditions; however, it is a new and evolving 
area of medicine that is still largely being investigated. With recent scientific advancements, SCT is 
moving away from the ethical dilemmas surrounding the use of embryos, and toward the efficacy of 
treatments (Phinney and Prockop, 2007; Robinton and Daley, 2012; Trounson and McDonald, 2015).
At present, SCs are routinely used as bone marrow transplantation, to treat hematological and 
immunological cancers and disorders, a practice that has existed for 50 years, and for longer than the 
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term “SCT” been a research topic (Copelan, 2006; Appelbaum, 
2007).
The only other SC-related treatment that is currently approved 
by the U.S. Food & Drug Administration (FDA) is an umbilical 
cord blood derived product produced by the New York Blood 
Center and used for specific hematological conditions (FDA, 
2012). The European Medicines Agency (EMA) approved its first 
SCT treatment in 2015 for the use of a corneal SC based therapy 
for treating corneal diseases (EMA, 2015). Both the FDA and 
EMA, as well as individual national level agencies, have policies 
in place for appropriate research and clinical translation of SCs 
(Bianco et al., 2013a).
Despite these regulations, authorities are increasingly con-
cerned about the rise in availability of SC therapies outside the 
approved indications or regulated clinical trials, with the potential 
to harm patients (Lau et al., 2008; Turner and Knoepfler, 2016).
Both the FDA and EMA have issued public and industry 
guidance recommending that any SCT undertaken should be 
explicitly approved, or as part of a clinical trial that has been 
allowed to proceed by the authorities (FDA, 2012; EMA, 2013). 
In addition, institutional organizations such as The International 
Society for Stem Cell Research (ISSCR) have produced their own 
information and recommendations patient handbook (ISSCR, 
2017). This is in part due to increased numbers of negative media 
stories emerging of desperate patients undergoing costly SCT 
abroad only to go onto develop complications (Berkowitz et al., 
2016; Kolata, 2016).
However, more recently, there has been a proliferation of TC 
closer to home, and the USA is now a major center for TCs offer-
ing therapies. A recent study found 351 companies operating 570 
TCs in the USA (Turner and Knoepfler, 2016), while there is some 
evidence of similar practices in Europe (Bianco et al., 2013a). In 
some cases, these TCs operate in a “gray area” in regulations. FDA 
guidelines are organized in a three-tier structure for deciding on 
the level of treatment oversight required (Chirba and Garfield, 
2011). The first tier covers non-manipulated SC transplants such 
as bone marrow; the second tier refers to “minimally manipu-
lated,” “homologous” SCs; and the third tier refers to “more than 
minimally manipulated,” “non-homologous” SCs, such as embry-
onic SC (ESC) or induced pluripotent SC (iPS). The description 
of tier two treatments stipulates that SCs “… that are, minimally 
manipulated, labeled or advertised for homologous use only, and 
not combined with a drug or device,” are subject to reduced over-
sight and FDA approval requirements (Parson, 2006). Similarly, 
in Europe, SCs are only viewed by the EMA as a drug if they 
are unmodified cells used for a biologically different function, or 
modified cells that have been substantially manipulated (includ-
ing expansion) (Martìn et al., 2014). Cells that require manipula-
tion (e.g., expansion) are legally treated as medicines, rather than 
transplants, by both the EMA and FDA meaning they have to 
pass rigorous regulatory requirements (Bianco et  al., 2013a). 
The aforementioned subclause is stated commonly by TCs and 
is considered to be legal authorization to treat with minimally 
manipulated SCs outside of a clinical trial protocol. In cases 
where TCs wish to offer treatments with cultured SCs, which have 
been expanded in the laboratory, the clause no longer applies, and 
the TC either has to operate according to approved clinical trial 
protocols (George, 2011), or to perform the procedure outside 
of the USA/European oversight. TCs around the world offer 
treatments for an array of conditions (Lau et  al., 2008; Turner 
and Knoepfler, 2016), with variable levels of evidence, while the 
majority are not performing these therapies as part of a credible 
clinical trial (George, 2011).
The Internet is a major resource for information-seeking 
patients who can find information from different sources. A 
number of criteria and instruments have been devised to assess 
health information quality, such as the JAMA score (whether the 
website shows the main transparency indicators: author, date, 
references, and ownership) (Silberg et al., 1997) or the presence 
of the health-on-the-net (HON) code seal, which is provided by 
a not-for-profit organization, the HON foundation (Boyer et al., 
1998).
While most of the studies on health information online focus 
on quality, in reference to patients seeking specific information 
on a condition (Chumber et al., 2015; Yaqub and Ghezzi, 2015; 
Bizzi et  al., 2017), the Internet  also plays a major role in the 
diffusion of beliefs. Analyzing the information available on the 
web can give an idea of how people develop their understanding 
and knowledge of health-related issues, such as vaccination or 
supplements (Maki et al., 2015; Aslam et al., 2017).
We have used an approach used in other similar studies to 
analyze the information on SCT that is available on the Internet 
(Maki et al., 2015; Aslam et al., 2017). Our aim was to investigate 
the quality of health information available but also how ordinary 
people gain knowledge about this topic. For this purpose, we 
used Google.com, the most widely and internationally used 
search engine, to gather a significant sample (200 websites) of 
the existing information. Then, we analyzed the type of website 
(for instance, whether it is a journalistic or a commercial one) 
and their content. Finally, we assessed two quality indicators, the 
presence of HONcode certification and the JAMA score.
MaTerials anD MeThODs
Data collection
We used the same established approach used for previous stud-
ies of health information online using Google.com (Maki et al., 
2015; Aslam et al., 2017). We forced the use of the international 
Google.com website using the address www.google.com/ncr (no-
country-redirect). To minimize personalization of the results, in 
particular that due to previous browsing history, the browser’s 
history and cookies were deleted before searching the string 
“SCT.” Of note, this will not completely prevent personalization 
of the results as the IP address would provide our location in the 
UK. We collected the first 200 websites returned in the search 
engine result page (SERP). The Google ads on top of the page 
were not included in the analysis.
exclusion criteria
21 Websites were excluded from analysis, based on assessments 
of relevance (e.g., solely relating to veterinary applications or 
products not including SC), accessibility (e.g., sites that denied 
access or websites that required membership or payment), and 
generalization (e.g., website results that when clicked on were not 
Table 1 | Criteria used in website analysis.
criteria Description/example
criteria for all websites
Typology Commercial, government, health portal, journalism, 
not-for-profit, professional, scientific journal, treatment 
center (TC), and other (those not fitting in any of the 
previous typologies)
Medical specialties/
treatments discussed
Neurology (spinal cord injury and Parkinson’s 
disease), musculoskeletal (osteoarthritis), etc.a
SC source Adult stem cells (ASCs), embryonic SCs (ESCs), and 
induced pluripotent SCs (iPSs)
Tone of content about 
stem cell therapy (SCT)
Positive, neutral, and negative
Ethical stance on SCT Positive, neutral, and negative
Controversial issues Efficacy, ESC use, cost, etc.
Geographic distribution 
of SCT availability
Country, region (Central America), and US state
Health-on-the-net code 
certification
Certificate link present on webpage
criteria specific for Tc websites
SC source ASCs (bone marrow, adipose tissues, etc.), ESCs, 
and iPSs
Geographic distribution 
of TC
Country, region (Central America), and US state
aSpecialties were indexed into 24 medical specialty groupings based on to the U.S. 
National Library of Medicine (2014). When an appropriate MeSH category did not 
exist, a suitable alternative was agreed on (e.g., “non-specific,” “cosmetic,” and 
“rejuvenation”).
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specific to the search topic, or social media pages with frequently 
changing user content). This left a total of 179 websites included 
in the final analysis.
There was one instance of two websites from the same treatment 
center (TC). However, because our aim was to analyze website 
results available from a Google search, not to identify individual 
TCs or websites owners, the duplicate was not removed. In addi-
tion, we cannot exclude the possibility that multiple websites may 
be owned by the same parent company.
Data analysis and scoring
Websites were individually visited and data recorded according 
to their typology, whether or not they display the HONcode 
certification for information quality, and the presence or not of 
each of the four JAMA criteria (author, date of writing or update, 
references to evidence statements, and indication of the owner-
ship of the website) (Silberg et al., 1997). For each of these four 
criteria, we assigned a score of 1 if the information was present, 
or 0 if absent or unclear.
Website content was then analyzed for an emerging set of cri-
teria. As the structure of the websites varied significantly based on 
the typology of the site, we adopted a flexible approach to analysis, 
to obtain relevant data. In some cases, the information was clearly 
defined on the landing page. In other websites, the landing page 
was frequently a generic page with little or no information, and 
analysis of further pages was required to obtain the same level of 
data. The criteria assessed are listed in Table 1.
statistical analysis
Frequencies of website typologies were compared using a two-
tailed Fisher’s exact test contingency table using GraphPad 
Software. When multiple comparisons were performed, we 
adjusted the P value using the Bonferroni correction. For this 
purpose, the level of significance was set by dividing the P value 
of 0.05 by the number of comparisons performed. Multiple 
comparisons of JAMA score were performed using the Kruskal–
Wallis non-parametric test with correction for multiplicity using 
GraphPad. Hierarchical cluster analysis was used to visualize 
common patterns in webpage content as previously described 
(Yaqub and Ghezzi, 2015) was performed using Genesis software 
version 1.8.1 for Windows (Sturn et al., 2002).
resUlTs
composition of the google serP
As shown in Figure  1, websites from treatment centers (TCs) 
offering SCT represent the main typology, with 44% of the search 
results, followed by news websites (22%). In the top 10 results, 
however, journalism websites are less visible and professional 
websites are significantly more represented (30%, 3/10, in the top 
10 as compared with 9%, 16/179, in the rest of the SERP).
specialties Mentioned by Websites or in 
Treatments Offered by Tcs
To investigate whether therapeutic indications (specialties) were 
discussed differently by different types of websites, we performed 
a sub-analysis the results of which are shown in Figure 2. There 
were substantial variations in the types of website discussing each 
specialty. Neurological treatments were mentioned across all 
website types, while musculoskeletal treatments were discussed 
to a similar extent, but predominantly by TCs, commercial, 
journalism, and professional websites. Musculoskeletal treatment 
encompassed conditions such as [osteoarthritis, rheumatoid 
arthritis, and joint (spine, shoulder, hip, knee, ankle, and elbow) 
injury/damage/degeneration].
Within the “musculoskeletal” subcategory the number of 
those from not-for-profit organizations (observed frequency: 3 
out of 14 in total in this category, 21%) and scientific journals 
(SJs) (2 out of 11, 18%) were underrepresented compared to the 
whole SERP, where “musculoskeletal” was mentioned in 62% of 
websites (expected frequency).
Conversely, 71 out of 78 (91%) of the TC discussed “muscu-
loskeletal” compared to the 62% expected from the frequency in 
the entire SERP. Journalistic websites tended to underrepresent 
the categories “nutrition and metabolism” (mentioned only in 
3 of 40 journalistic websites, 8%) and “immunological” (3 of 
40, 8%) compared with their frequency in the whole search 
(both 27%).
Discussion relating to “neoplasms” was more a common 
topic in professional websites (mentioned in 10/16 professional 
websites, 63%, compared to 26% in the whole SERP), while TCs 
discussed “respiratory” topics more than would be expected 
(28/78 TC websites, 36% compared to 22% websites mentioning 
“respiratory” in the whole SERP). Outside of the top 10 most 
FigUre 2 | Composition of websites mentioning different disease/specialties. Data are expressed as a percentage of the total number of websites mentioning a 
type of intervention. Data labels indicate the number of websites. A red or green bubble indicates a disease/specialty, that is; respectively; significantly (P < 0.05) 
more or less represented in that typology of website; compared with the frequency of the same disease/specialty in the whole search. N in each typology as 
reported in Table 1. Statistical significance was calculated comparing the observed frequency and the expected one by Fisher’s test.
FigUre 1 | Typologies of websites in the full search engine result page and in the top 10 results by Google. Data are expressed as percentage in the whole search 
(left) or the top 10 websites returned by Google. *Significantly different (P = 0.048 by two-tailed Fisher’s test).
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discussed treatment categories, the number of professional 
websites discussing “wounds and injuries” was also significantly 
higher (7 of 16, 43% versus 28/179, 16%, in the whole SERP).
We then analyzed each website for the diseases discussed in 
general terms relating to SCT or as an indication for treatment 
offered by TCs (according to their websites). Figure 3 shows the 
list of specialties mentioned by non-TC websites (blue bars), 
and those for which SCT is offered by TCs (orange bars), both 
classified using the MESH terms. The specialty mentioned most 
in non-TC websites was “neurological” (75%), followed by “car-
diovascular” (48%), while the most frequent indication for which 
SCT is offered by TCs was musculoskeletal (89%) followed by 
neurological (47%).
Another question we addressed was how many specialties 
are offered in websites from TCs. A first observation was that 
we could split TCs as specialist versus generalist. Almost half 
FigUre 3 | Treatment indications discussed by websites or offered by treatment centers (TCs). Percentage of non-TC websites that discussed each specialty in 
relation to stem cell therapy (blue bars) compared with treatments offered by TC (orange bars) as detected from their websites. Disease classification as described in 
Section “Materials and Methods.” Diseases/indications with a value of <5% in both groups are not shown. Brackets show the significance level of the difference in 
frequency in the two groups by a two-tailed Fisher’s exact test.
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(n = 35; 45%) of the TCs specialize in only 1 treatment category, 
10% offer 2, and the remaining 45% offer between 3 and 18 
treatment categories, the average number of categories being 
4.8. A hierarchical cluster analysis visualization of the treatment 
categories offered shows that the majority of TCs that specialize, 
do so in “musculoskeletal” treatments (Figure 4).
geographical Distribution of Tcs
Websites of TCs can be used as proxies to study the geographical 
distribution of TCs offering SCT. TCs identified in our research 
are focused in the USA, with 65% (n = 66) of all sites globally, 
while the remaining 35% (n =  36) are spread throughout the 
world in single figure numbers (Figure 5). Notably, there are no 
TCs with a website returned by Google.com in Western Europe.
Eight websites advertise SC culturing, and an additional three 
are unclear on the subject. The websites that definitively offer the 
service are based in USA (2), USA/Cayman Islands (2), USA/
Jamaica (1), USA/Mexico (1), Mexico (1), and Thailand (1).
Of the TCs based in the USA, a total of at least 163 TC sites 
(TCs frequently have multiple sites within each state and/or in 
interstate locations, the details for which are not always fully 
detailed) were distributed widely across 40 out of 50 states, 
as follows: Florida, 16; California, 14; Arizona, 12; Texas, 12; 
New York, 8; Colorado, 7; Ohio, 6; Pennsylvania, 6; Virginia, 6; 
Oklahoma, 5; Georgia, 4; Illinois, 4; Maryland, 4; Minnesota, 4; 
Missouri, 4; Nevada, 4; New Jersey, 4; Utah, 4; Alaska, 3; Indiana, 
3; Kentucky, 3; Arkansas, 2; Iowa, 2; Kansas, 2; Louisiana, 2; 
Michigan, 2; Mississippi, 2; New Mexico, 2; Oregon, 2; Tennessee, 
2; Vermont, 2; Washington, 2; Hawaii, 1; Idaho, 1; Massachusetts, 
1; Nebraska, 1; North Carolina, 1; West Virginia, 1; Wisconsin, 1; 
and Wyoming, 1.
When analyzing all websites, not only those from TCs, anec-
dotal discussion suggests a more widespread availability of SCT. 
While availability is still predominantly focused in Northern 
America (103), every geographical region is represented with 
45 websites discussing availability in Asia, 28 in Europe, 22 in 
Central America, 9 in Oceania, 8 in the Caribbean, 4 in Southern 
America, 3 in the Middle East, and 2 in Africa.
Of the 78 websites from TCs, only 10 explicitly mentioned 
that SCT was part of a clinical trial (for instance, the websites of 
the Mayo clinic and that of the MD Anderson Hospital, see Data 
Sheet 1 in Supplementary Material). Others specifically stated 
that “treatments offered are not research or a clinical trial”1 or 
that they “are part of an ongoing FDA clinical trial study and now 
also offers SCT to patients not enrolled in the study.”2
sources of stem cells and controversial 
issues
The first issue we focused on was whether the source of stem cells 
used was adult stem cells (ASCs) or ESCs. As shown in Figure 6, 
1 http://www.emoryhealthcare.org/sports-medicine/stem-cell-treatment.html 
(accessed 7/2017). Archived at http://www.webcitation.org/6kXrBDpro.
2 https://www.spinemd.com/treatments/stem-cell-therapy (accessed 7/2017). 
Archived at http://www.webcitation.org/6kn6mtOba.
FigUre 4 | Hierarchical clustering of websites from treatment centers (TCs). Websites were clustered according to the specialties described in their websites as 
offered by the TC.
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ASC from bone marrow or adipose tissue is the sources of stem 
cells predominantly used for treatments by TCs. It should be 
noted that these are the sources used for treatment. Although 
42 (54%) TC websites discuss both ESCs and ASCs as potential 
sources, none of them uses ESC for their treatments. It should 
also be noted that multiple sources were frequently used by 
individual TCs.
We performed a subjective assessment of the tone used by each 
website, whether positive about SCT, negative or neutral. 100% 
of commercial and TC websites had a positive outlook when 
discussing SCT (commercial websites, 6/6 positive; TC, 78/78 
positive). Other website typologies had varying ratios of positive 
and neutral website as follows: professional, 13/16 positive (81%), 
3/16 neutral (19%); government, 3/4 (75%) positive, 1/4 (25%) 
neutral; not-for-profit, 8/14 (57%) positive, 6/14 (43%) neutral; SJ, 
6/11 (55%) positive 5/11 (45%) neutral; journalism, 14/40 (35%) 
positive, 26/40 (65%) neutral; and health portal (HP), 2/7 (29%) 
positive, 5/7 (71%), neutral. No websites had an overall negative 
approach to SCT. Two websites had an overtly ethical stance 
toward the use of ESCs, made clear by direct statements, such as 
“…100% Pro-life and believe that the harvesting of embryonic 
stem cells is in fact taking a life…” [About SCT: (Online) Indy 
Regenerative Medicine; available from: http://indyregen.com/
about-stem-cell-therapy/ (accessed 10/2016). Archived at http://
www.webcitation.org/6quuhy5Vg] in one case, and by a clear 
focus on ASCs and an affiliation to a “pro-life” website in the 
case of the other [Life-Saving Stem Cells: Discover, Learn, share: 
(Online) Stem Cell Research Facts; available from: http://www.
stemcellresearchfacts.org/ (accessed 10/2016). Archived at http://
www.webcitation.org/6quwQDBoE].
Another aspect of our research was to look at controversial 
issues that were discussed across all website typologies. One of 
these topics was the discussion of the cost of treatments, which 
is additionally one of the criteria for “health information qual-
ity” according to the Association of Health Care Journalists 
(Schwitzer, 2004). It is important to note that, of the websites from 
TCs, only 30% talked about the costs of treatment in any way, and 
most of these still did not directly offer prices on their websites.
health information Quality criteria: JaMa 
score and hOn code certification
Figure 7 reports the JAMA score across different typologies of 
websites. Commercial and TC websites scored lower than most 
categories. JAMA score of TC websites was significantly lower 
than that of HPs, journalism, not-for-profit and SJs (P < 0.0001 by 
Kruskal–Wallis multiple comparisons test; adjusted P value after 
correction for multiple comparison using statistical hypothesis 
testing). Not-for-profit websites had a lower JAMA score than 
journalism (P  =  0.0251) and SJs (P  =  0.0004). Professional 
websites scored lower than SJs (P = 0.0033). A criterion used in 
health information quality is that the JAMA score should be at 
FigUre 5 | Global distribution of treatment centers with a web page in English. Data are shown as a heat map; darker color indicates higher numbers. Full results: 
USA, 66; Australia, 4; India, 4; Thailand, 4; Canada, 2; Cayman Islands, 2; China, 2; Mexico, 2; Panama, 2; South Korea, 2; Ukraine, 2; Chile, 1; Iran, 1; Jamaica, 1; 
Malta, 1; New Zealand, 1; Philippines, 1; Russia, 1, Serbia, 1; South Africa, 1; and Turkey, 1.
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least 3, and the analysis with this criterion parallel those obtained 
for the median score, with TC (0% of websites with JAMA score 
≥3) and commercial websites (25%) scoring the lowest and SJs 
the highest (100%).
Only nine websites (5% of the total) displayed an HON code 
certificate: five HPs, three journalistic sites, and one profes-
sional site.
DiscUssiOn
Our study found that websites from TC are the most common 
website categories, accounting for just over 40% of the SERP. 
They were also given high visibility by Google, being present in 
the same proportion in the top 10 websites returned. This is in 
contrast with what we observed with commercial websites in 
this and other studies, which are usually given a low ranking by 
Google and are never present in the top 10 results.
We were also surprised that SCT was offered by so many 
TCs, as the scientific literature usually describes SCT as an area 
of clinical research that has not yet made the final translational 
step (Bianco et al., 2013b). On the other hand, the prevalence 
of the musculoskeletal specialty as a treatment offered by TCs 
is consistent with this indication also being prevalent among 
those currently addressed by clinical trials (Trounson and 
McDonald, 2015).
The second most frequent category of websites is journalistic. 
The majority of these sites are examples of objective journal-
ism; however, we also found a number of cases where the story 
predominantly focused on sport stars’ treatments or patients’ 
miraculous recoveries, without going into depth about the realities 
of SCT (McKean, 2016; Owens, 2016; White, 2016). This media 
hype about athletes’ use of stem cells had already been highlighted 
by other studies (Caulfield and McGuire, 2012; Du et al., 2016).
The measure of trustworthiness by the JAMA score only 
assesses one basic dimension of health information quality, and 
its main limitation is that it does not take into account the content 
of the websites. However, within this limitation, we found that 
TCs have the lowest median score, even lower then commercial 
websites, which we found to score the lowest in several studies 
on different health topics (Maki et al., 2015; Aslam et al., 2017; 
Bizzi et al., 2017). The HON code encompasses more dimensions 
of information quality (Boyer et  al., 1998); however, only nine 
websites displayed an HON code certification and none of them 
where websites from TCs.
In theory, some typologies such as not-for-profits, SJs, and 
HPs should have a more independent and unbiased viewpoint. 
However, these three typologies only account for 18% of the 
websites in our research.
Another consideration we can make from the specialties dis-
cussed by journalistic and TC websites shown in Figure 1 is that, 
although neurological applications of SCT is the most newswor-
thy, musculoskeletal indications are the most commonly offered 
by TCs, which may indicate a difference between availability of 
treatments and public expectations.
We did not find TCs offering treatments using ESCs. While it is 
possible that some TC may not mention this on their websites, it is 
important to note that a similar study from 2007 showed a greater 
percentage use of fetal SCs (21%) and ESCs (11%) (Lau et al., 2008). 
FigUre 7 | Comparison of JAMA score in websites from different typologies. 
Data are reported as median and interquartile range. Numbers in parentheses 
indicate the number of websites in each category that could be scored for 
the JAMA criteria, excluding those no longer accessible at the time of the 
analysis. Legend: C, commercial; G, government; HP, health portal; J, 
journalism; NP, no profit; O, other; P, professional; SJ, scientific journal; TC, 
treatment center.
FigUre 6 | Sources of stem cells used by treatment centers. Numbers 
indicate the number of treatment centers (TCs). The chart does not include 
sources of stem cells used by only one TC (these were as follows: 
endothelial, IPC, dental, insulin producing, and retinal).
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On the other hand, only a few TCs were found in the 2007 study, 
indicating the expansion and marketization of SCT.
Although SCT may become a commonplace procedure, at 
present there is a mismatch between capabilities and expecta-
tions, and TCs are offering treatments whose efficacy is largely 
unproven.
Stem cells are a very popular subject and a 2009 study from 
the Pew Research Center found that 52% of Americans know 
the definition of stem cell in terms of pluripotentiality (Kohut, 
2009). How ordinary people come to know or believe what they 
do is an important research question (Hardin, 2014). We build 
knowledge from information available from different and varied 
sources. A 2015 study analyzed the portrayal of STC in daily 
English language newspapers and reported that press cover-
age focuses more on its translational potential rather than on 
ethical issues (Kamenova and Caulfield, 2015). Press coverage 
was very optimistic in terms of translational timelines, with an 
overwhelmingly optimistic view, particularly in the UK.
With the limitation that the study is restricted to websites 
in English, the present study shows the potential usefulness of 
studying websites returned by Google to analyze how the public 
gains an understanding of stem cells. In fact, a Google search 
returns a wide range of websites representing various types of 
news outlets, public health organizations, professional and com-
mercial organizations. Given that so many websites were actually 
from TCs, this might represent an easy way of analyzing their 
geographical distribution and type of procedures they perform. 
However, this is an issue where limiting our research to websites 
in English cannot give a reliable idea of the global distribution of 
TCs, and this could easily explain the prevalence of TCs in the 
USA.
Another issue is that of the personalization of the results 
returned by Google. On one hand, we acknowledge that a search 
cannot be completely anonymous, and the approach used of 
deleting cookies and browser’s history avoids personalization 
based on previous search behavior but does not hide the geoloca-
tion of the computer, that is, provided by the IP address of the 
network. On the other hand, this type of anonymized search may 
not be representative of the behavior of the average user, who will 
not take these precautions. However, it must be said that there is 
little scientific evidence that search personalization affects health 
search results greatly. The concept of Google creating a “filter 
bubble” though the personalization of search results provided 
became popular with the book “The Filter Bubble: What the 
Internet Is Hiding from You” by the political activist Eli Pariser. 
While this was taken up by various magazines, there is little 
empirical evidence for a search bubble in the scientific literature 
and, specifically in health-related searches, the only published 
research indicate that health searches are the least affected by 
personalization (Hannak et al., 2013). A recent study using 1,200 
virtual agents performing health searches after different training 
session of repeated searches on Google could not find any effect 
of previous searches on search results (Haim et al., 2016).
Of course, having a website displayed in the Google SERP 
does not mean that this will be read by the users. For instance, 
some users may then only look at news websites. Analyzing this 
aspect would require performing studies on human volunteers, 
for instance using eye-tracking software (Granka et  al., 2004). 
Another important factor in the attention website receive is 
whether they are in the top 10 results returned by Google. In 
other studies, we consistently found that Google ranks commer-
cial websites low (Chumber et al., 2015; Maki et al., 2015; Yaqub 
and Ghezzi, 2015; Aslam et al., 2017), and this is also what we 
observed here as the first commercial website ranked 47th in the 
present search, although the small number of commercial websites 
in the whole search (six) make it impossible to draw conclusions. 
However, in previous studies on influenza prevention, influenza 
vaccine (Maki et  al., 2015), and migraine (Yaqub and Ghezzi, 
2015), the ranking by Google favored evidence-based medicine 
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approaches, giving complementary/alternative medicine and 
anti-vaccine websites a low ranking. In the present sample, TCs 
were present with the same frequency in the top 10 websites and 
the whole search.
Finally, our work should be paralleled by a similar study on the 
information available on social media, which we did not analyze 
in this study and where many issues, from information quality 
and the bubble effect, may well be quantitatively different from 
websites. Although the most recent study available from the Pew 
Research Institute, indicated that, in 2013, when seeking health 
information, users use mainly search engines (77%) and only 1% 
social network (Fox and Duggan, 2013), these percentages are 
likely to have changed and, in any case, social media may expose 
users to health information even if this is not searched for.
In conclusion, this study shows that there is insufficient 
unbiased, evidence-based information available about SCT. TCs 
in many countries offer SCT, frequently operating in a “gray area” 
of regulation, and these have a good visibility on the Internet. 
Without sufficient regulatory oversight, there is a risk of SCT 
becoming a form of complementary medicine that is at best 
unscientific and at worst is unsafe.
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